Regioselective Antibody Modification via Flow Microreactor Mixing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing antibody derivatives are inefficient in achieving rapid and regioselective modification, particularly in biological polymers like antibodies, due to thermodynamics-dominated reactions which are unsuitable for flow microreactors.

Innovation Solution

A method involving a compound with an affinity substance and a reactive group is used in a flow microreactor to rapidly produce regioselectively modified intermediate antibodies and derivatives, utilizing a micromixer for quick mixing and reaction in a flow microreactor system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If batch process mixing is used for antibody modification, then mixing is simple to implement, but mixing time is long (at least a few seconds) and reaction speed is slow

Engineering Contradiction:
Improvemixing implementation simplicityVSAvoidmixing time
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The patent employs a flow microreactor system where solutions are mixed through controlled fluid flow in microchannels. The micromixer uses hydraulic principles to achieve rapid mixing by creating laminar flow patterns and enhancing diffusion through the small channel dimensions, reducing mixing time from seconds to milliseconds while maintaining operational simplicity

Inventive Principle:
Principle #29Pneumatics and hydraulics

Solution Approach 2:

The patent transitions from bulk batch mixing to microscale channel flow mixing. By reducing the mixing dimension from macroscopic batch vessels to microscopic channel networks, the diffusion distance is dramatically reduced, enabling rapid mixing without complex mechanical stirring mechanisms

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Stability of the object's composition

If thermodynamics-dominated reactions are used for antibody modification, then reaction equilibrium is favorable, but reaction speed is slow and regioselectivity is poor

Engineering Contradiction:
Improvereaction equilibrium stabilityVSAvoidreaction speed
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

The patent changes the reaction parameters by using flow microreactor conditions that enhance mass transport and reduce diffusion limitations. The continuous flow regime and precise residence time control allow the reaction to proceed under kinetic control rather than thermodynamic equilibrium, achieving both high reaction speed and improved regioselectivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent incorporates a micromixer that pre-mixes reagents before they enter the reaction zone, ensuring homogeneous distribution of reactants. This preliminary mixing action eliminates diffusion barriers and allows the reaction to proceed rapidly with high regioselectivity from the outset, rather than relying on slow equilibrium processes

Inventive Principle:
Principle #10Preliminary action

3Productivity

If conventional mixing methods are used for rapid reaction, then reaction speed can be increased, but mixing complexity and device complexity increase

Engineering Contradiction:
Improvereaction speedVSAvoidmixing device complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The micromixer design allows the flow pattern itself to generate the mixing action through laminar flow dynamics and diffusion enhancement in microchannels. The system uses the fluid's own flow characteristics to achieve rapid mixing without external mechanical mixing elements, keeping the device simple while enabling fast reactions

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables rapid and efficient production of regioselectively modified antibodies and derivatives with high modification ratios and purity, overcoming the limitations of traditional methods by leveraging kinetics in the flow microreactor environment.

Implementation Method 1

The mixing time required for obtaining a homogeneous solution depends on the diffusion distance of molecules in the solution. In the FMR, a micromixer having a microstructure is used to enable mixing and reaction of a plurality of components in a minute environment. Mixing of solutions by the micromixer in the FMR is mixing in minute channels, and the diffusion distance of molecules is small.

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

the reagent comprises a compound comprising an affinity substance to an antibody and a reactive group to an antibody

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Data Source

PatentUS20240218015A1Methods for producing intermediate antibodies regioselectively modified, and antibody derivatives regioselectively having bioorthogonal functional group or functional substance
Publication Date: 2024.07.04 AJINOMOTO CO INC
  • US20240218015A1 patent drawing
  • US20240218015A1 patent drawing
  • US20240218015A1 patent drawing

AI summary

A method for producing an intermediate antibody regioselectively modified, which comprises:(1) mixing a solution comprising an antibody material and a solution comprising a reagent for regioselectively modifying an antibody in a micromixer to form a mixture comprising the antibody material and the reagent,wherein the reagent comprises a compound comprising an affinity substance to an antibody and a reactive group to an antibody; and(2) passing the mixture through a reaction channel to allow the antibody material and the reagent to react in the reaction channel to form a solution comprising an intermediate antibody regioselectively modified,wherein the processes (1) and (2) are continuously performed in a flow microreactor,is capable of rapidly producing a desired antibody derivative regioselectively having a functional substance or functional substances.